DVx Inc.

Tokyo Stock Exchange:3079.T

Sector

🏥 Health Care

Industries

🩺 Medical Instruments

Location

Japan

Market Cap

USD 67.42 M

Share Price

USD 6.44

Avg Daily Volume

13,632

Change (1 day)

-1.19%

Change (1 year)

3.63%

Change (YTD)

8.20%

DVx Inc. Shareholders' Equity for the year ending March 31, 2025: USD 60.85 M

DVx Inc. Shareholders' Equity is USD 60.85 M for the year ending March 31, 2025, a 0.11% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.

DVx Inc. Shareholders' Equity for the year ending March 31, 2024 was USD 60.78 M, a -13.29% change year over year.
DVx Inc. Shareholders' Equity for the year ending March 31, 2023 was USD 70.09 M, a -0.65% change year over year.
DVx Inc. Shareholders' Equity for the year ending March 31, 2022 was USD 70.55 M, a -1.38% change year over year.
DVx Inc. Shareholders' Equity for the year ending March 31, 2021 was USD 71.54 M, a 1.67% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Shareholders' Equity	Cash and Short-Term Investments	Receivables	Inventory

Tokyo Stock Exchange: 3079.T

DVx Inc.

CEO	Mr. Hiroshi Shibasaki
IPO Date	April 25, 2007
Location	Japan
Headquarters	Mejiro Nakano Building
Employees	316
Sector	🏥 Health Care
Industries Medical Instruments

Description

DVx Inc. engages in the import/export of medical devices and related peripheral devices in Japan. The company sells arrhythmia-related products, such as cardiac pacemakers, implantable cardioverter defibrillators, electrode catheters, and ablation catheters. It also offers ischemia-related products, including excimer laser systems; RADPAD, which reduces scatter radiation exposure to medical personnel during fluoroscopy procedures; RADNEK that reduces scatter radiation exposure to the thyroid in medical personnel during fluoroscopy procedures; RADCAP, which reduces scatter radiation exposure to the head of medical personnel during fluoroscopy procedures; and resolution/resolution SD and wonder belt products. In addition, the company engages in the research, development, manufacture, sale, repair, and leasing of medical devices and related peripheral devices; provision of internal and external medical and medical device-related general consulting and services; and medical publishing and market research activities. DVx Inc. was founded in 1986 and is headquartered in Tokyo, Japan.